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Abstract
Ultrasound molecular imaging utilizes targeted microbubbles to bind to vascular targets such as 
integrins, selectins, and other extracellular binding domains. After binding, these microbubbles are 
typically imaged using low pressures and multi-pulse imaging sequences. In this article, we 
present an alternative approach for molecular imaging using ultrasound which relies on 
superharmonic signals produced by microbubble contrast agents. Bound bubbles were insonified 
near resonance using a low frequency (4 MHz) and superharmonic echoes were received at high 
frequencies (25–30 MHz). While this approach was observed to produce declining image intensity 
during repeated imaging in both in vitro and in vivo experiments due to bubble destruction, the 
feasibility of superharmonic molecular imaging was demonstrated for transmit pressures which are 
sufficiently high to induce shell disruption in bound microbubbles. This approach was validated 
using microbubbles targeted to the αvβ3 integrin in a rat fibrosarcoma model (n=5), and combined 
with superharmonic images of free microbubbles to produce high contrast, high resolution 3D 
volumes of both microvascular anatomy and molecular targeting. Image intensity over repeated 
scans and the effect of microbubble diameter were also assessed in vivo, indicating that larger 
microbubbles yield increased persistence in image intensity. Using ultrasound-based acoustic 
angiography images rather than conventional B-mode ultrasound to provide the underlying 
anatomical information facilitates anatomical localization of molecular markers. Quantitative 
analysis of relationships between microvasculature and targeting information indicated that most 
targeting occurred within 50 µm of a resolvable vessel (>100 µm diameter). The combined 
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information provided by these scans may present new opportunities for analyzing relationships 
between microvascular anatomy and vascular targets, subject only to limitations of the current 
mechanically-scanned system and microbubble persistence to repeated imaging at moderate 
mechanical indices.
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Introduction
In contrast to anatomical imaging methods, molecular imaging reveals functional 
information about tissue pathophysiology based on the accumulation of a molecular tracer. 
However, the value of a molecular imaging technique is often greatly enhanced by 
combining it with anatomical imaging in order to visualize the distribution of the marker. 
Clinically, this approach is used in systems combining computed tomography with positron 
emission tomography (PET-CT) or single photon emission computed tomography (SPECT-
CT). These combined systems have demonstrated higher accuracy in localizing 
abnormalities, often resulting in changes in treatment plans in cancers of the lung, thyroid, 
breast, and prostate (Cerfolio et al. 2004; Tharp et al. 2004; Roach et al. 2006; Lerman et al. 
2007; Garami et al. 2012; Soyka et al. 2012). In ultrasound molecular imaging, images of 
targeted microbubble contrast agent are typically overlaid on anatomical B-mode images to 
allow visualization of the spatial distribution of markers. Due to the intravascular nature of 
microbubbles, they are particularly well-suited to the study of endothelial markers of 
disease. For this reason, many recent studies in ultrasound molecular imaging have 
investigated angiogenesis and related processes of vascular remodeling and inflammation 
(Kaufmann and Lindner 2007; Voigt 2009; Anderson et al. 2011; Inaba and Lindner 2012; 
Hyvelin et al. 2014; Wang et al. 2014).
While ultrasound possesses advantages over other molecular imaging modalities due to its 
relatively low cost, portability, and lack of ionizing radiation, it also has limited penetration 
depth at the high frequencies required to achieve sub-millimeter resolution. In addition, the 
ultrasound image providing anatomy is quite different in nature from CT or magnetic 
resonance imaging (MRI) images that provide anatomical information for PET or SPECT, as 
contrast in B-mode ultrasound images is the result of differences in acoustic backscattering 
from tissue, and depends on the size, distribution, and acoustic impedance of the scatterers. 
Ultrasound also has a limited field of view compared to whole-body imaging modalities. 
The development of microbubble contrast agents, which provide substantially higher levels 
of acoustic scattering relative to erythrocytes, has greatly enhanced the ability to use 
ultrasound to image both vascular anatomy and blood flow dynamics. Contrast-enhanced 
ultrasound (CEUS) imaging with high frequency transducers has allowed imaging of small 
vessels with resolutions on the order of a few hundred microns, providing potential for 
assessing angiogenesis and vascular remodeling with both targeted and non-targeted 
microbubbles (Ellegala et al. 2003; Leong-Poi et al. 2005; Liu et al. 2008; Willmann et al. 
2008; Willmann et al. 2010; Pysz et al. 2011; Wang et al. 2015a). High-resolution molecular 
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imaging is particularly valuable for pre-clinical imaging in small animal models and studies 
in which small anatomical locations are of interest, although high frequency contrast-
specific imaging is technically challenging to implement (Rychak et al. 2007; Foster et al. 
2009; Foster et al. 2011; Yan et al. 2012; Denbeigh et al. 2014; Liu et al. 2015).
An alternative approach to high frequency CEUS involves the use of dual-frequency 
transducers, with a low frequency transmit pulse used to excite microbubbles near their 
resonance and a high frequency element receiving only higher harmonic echoes produced by 
microbubbles (Gessner et al. 2010). Detection of these “superharmonic” signals produced by 
microbubbles with multi-frequency transducers was first reported by Bouakaz et al. 
(Bouakaz et al. 2003) and by Kruse and Ferrara (Kruse and Ferrara 2005), although these 
early investigators did not use this technology to develop the 3-D microvessel images 
demonstrated more recently by Gessner et al. (Gessner et al. 2013). The “transmit low/
receive high” dual-frequency approach has previously been utilized in molecular imaging by 
Ferrara et al. (Hu et al. 2010; Hu et al. 2013). When transmitting at 2 MHz and receiving at 
15 MHz, Hu et al. demonstrated approximately a two-fold improvement in spatial resolution 
in vitro relative to multi-pulse techniques employed by commercial scanners (Hu et al. 
2013). The use of a low transmit frequency improves the penetration depth relative to 
contrast imaging at a single high frequency. For example, at a depth of 1.5 cm and an 
attenuation of 0.2 dB/cm/MHz, two-way attenuation in a 25 MHz scan is 15 dB but is only 
8.7 dB with a 4/25 MHz dual-frequency scan. Transmitting at a lower frequency also more 
closely corresponds to the resonance frequencies of most commercially-available 
microbubble contrast agents (Doinikov et al. 2009; Faez et al. 2011; Helfield and Goertz 
2013), improving image contrast, which is vital in molecular imaging when relatively few 
microbubbles are typically present.
Using this “transmit low/receive high” approach with prototype dual-frequency, 
mechanically-steered transducers connected to a commercial ultrasound system, we have 
recently demonstrated the ability to form high resolution images of vasculature with 
resolutions of approximately 150 µm and with almost no tissue interference. We call this 
technique “acoustic angiography” due to the images’ similarity to CT or MR angiography. 
While commercial ultrasound scanners perform contrast-specific imaging within a single 
transducer bandwidth, our approach forms images using only received signals at frequencies 
at least three times higher than the transmitted frequency. Our group recently found that 
using a receiving center frequency at least three times higher than the transmit center 
frequency produces the highest contrast-to-tissue ratios, as tissue amplitudes decrease more 
rapidly than microbubbles amplitudes with increasing frequency (Lindsey et al. 2014). In 
addition, while using higher harmonics to form images (i.e. 5th rather than 3rd) may further 
reduce sensitivity, it provides the increased resolution necessary for resolving vasculature 
<300 µm in diameter. Using these 3-D imaging volumes and quantitative metrics of vascular 
signatures, we have further demonstrated the ability to distinguish between healthy and 
cancerous tissues (Gessner et al. 2012a; Shelton et al. 2015). High specificity to contrast due 
to transmitting at low frequencies and receiving at much higher frequencies allows 
suppression of tissue artifact while preserving frame rates without requiring a separate 
control image to be acquired and subtracted. This simplifies the imaging protocol and 
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eliminates artifacts due to physiological motion or misregistration of the control and contrast 
images.
Several studies have found that another means for improving the sensitivity of ultrasound 
molecular imaging is by adjusting the size distribution of the microbubble population (Talu 
et al. 2007; Sirsi et al. 2010; Streeter et al. 2010). In dual-frequency superharmonic imaging, 
we have recently observed that using a population with larger microbubbles results in 
superharmonic signals with increased amplitude (Lindsey et al. 2014). This effect arises 
because larger microbubbles are capable of producing superharmonic signals over a greater 
number of acoustic pulses (Lindsey et al. 2015).
Despite the promising resolution of dual-frequency superharmonic imaging, our own recent 
studies indicate that dual-frequency superharmonic imaging is at least partially destructive to 
microbubbles (Lindsey et al. 2015), which makes implementation of superharmonic 
molecular imaging a significant challenge. The dual-frequency transducer design is critical 
for separation of tissue and microbubble echoes, as a wide separation between transmit and 
receive bandwidths ensures that only microbubble echoes are received at the higher 
frequencies. However, the focal spot is larger for the low frequency element than the high 
frequency element. The result is that as both transducers are swept in unison to form a 2-D 
image, a stationary microbubble is subjected to multiple off-axis, low frequency transmit 
pulses before the center of the dual low- and high- frequency focus is aligned to the 
microbubble. While many commercially-available systems utilize techniques such as 
synthetic aperture processing and broad beam insonation to ensure uniform acoustic 
intensity over wide regions of interest for microbubble imaging (Brock-Fisher et al. 1996), 
the transducers utilized by these systems do not have the necessary bandwidth to perform the 
superharmonic contrast imaging enabled by the described prototype transducer.
Although the mechanical indices used in superharmonic imaging are below the maximum of 
0.8 for which safety has been evaluated for Definity® (Lantheus Medical Imaging, N. 
Billerica, MA)(Imaging 2013), our previous studies indicate that microbubble shell 
disruption is required to produce superharmonic signals (approximately 300 kPa or greater 
at 4 MHz)(Lindsey et al. 2015), which may present a challenge for molecular imaging if 
bound microbubbles might be destroyed before the superharmonic signal they produce can 
be detected. Fortunately, there is evidence that the same microbubbles can produce 
superharmonic echoes in response to multiple insonations (Kruse and Ferrara 2005; Lindsey 
et al. 2015), suggesting that it may be possible to balance production of superharmonic 
signals and microbubble destruction in such a way as to enable molecular imaging.
In this article, we describe the development of an approach for high resolution molecular 
imaging based on microbubble superharmonic echoes. This technique uses spectrally 
separated transmit and receive bandwidths to form images of bound microbubbles rather 
than the low-mechanical index multi-pulse sequences that are commonly used (Phillips 
2001). Intensity and persistence of the superharmonic signals in these images were evaluated 
through in vitro experiments in micro-cellulose tubes and in vivo imaging studies in a 
subcutaneous tumor model. When combined with a sequentially-acquired acoustic 
angiography volume, the developed approach provides simultaneous 3-D visualization of 
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both microvascular structure and molecular markers of angiogenesis with unprecedented 
resolution. While the B-mode ultrasound images which typically provide anatomical 
information in ultrasound molecular imaging are difficult to display in 3D and require an 
experienced user to understand and interpret differences between tissue types, the vascular 
anatomy provided by acoustic angiography can be easily displayed in 3D and may be readily 
interpreted by users with limited previous ultrasound experience. Finally, microvascular 
information in the acoustic angiography volume can be analyzed using metrics such as 
vascular density (Dunleavey et al. 2014) or tortuosity to quantitatively assess vascular 
remodeling (Gessner et al. 2012a; Shelton et al. 2015). When combined with molecular 
targeting information, this may provide new information regarding the spatial distribution of 
vascular biomarkers.
Materials and Methods
Acoustic angiography imaging experiments were performed with modified VisualSonics 
RMV probes and a Vevo 770 ultrasound scanner (VisualSonics, Toronto, Canada). In this 
work, modified RMV710B (25 MHz center frequency) and RMV707 (30 MHz center 
frequency) transducers were used, each with an additional 4 MHz annular element which is 
confocal to the high frequency element (Gessner et al. 2010). The low frequency element is 
used only for transmitting, while the high frequency element only receives higher harmonics 
produced by microbubbles. The two single-element transducers are mechanically steered to 
acquire a 2-D image and can be translated using a motion stage to combine multiple 2-D 
images into volumetric data.
Microbubble preparation for in vitro studies
Lipid solutions (Streeter et al. 2010) were formulated with a 9:1 molar ratio of 1,2-
distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-methoxy (polyethylene–glycol)-2000 (DSPE-PEG2000) (Avanti 
Polar Lipids, Alabaster, AL) in a solution containing propylene glycol 15% (v/v), glycerol 
5% (v/v), and phosphate-buffered saline (PBS) 80% (v/v). 1.5 mL aliquots of this lipid 
solution were placed in sealed 3 mL glass vials and the air headspace was exchanged with 
decafluorobutane (DFB) gas purchased from Fluoromed (Round Rock, TX, USA). 
Microbubbles with DFB gas cores and phospholipid shells formed spontaneously when 
agitated in a Vialmix device (Lantheus Medical Imaging, N. Billerica, MA). The 
concentration, and diameter of microbubbles in this emulsion was measured via (single 
particle) optical techniques (Accusizer 780, Particle Sizing Systems, Santa Barbara, CA, 
USA) (Satinover et al. 2014). For targeted bubbles, a biotinylated PEG was used (DSPE-
PEG2000-Biotin) (Zhao et al. 2004) to replace 50% of the DSPE-PEG2000. Microbubble 
emulsions were washed with four centrifugations, and produced a stable population of 
microbubbles with a diameter of approximately 1.4 µm (Feshitan et al. 2009).
In vitro experiments
Transducer calibration and spatial mapping of the low frequency transmit beam was 
performed with a calibrated needle hydrophone (HNA 0400, Onda Corp., Sunnyvale, CA) 
on a computerized motion stage (Newport XPS, Irvine, CA) and digitized using a digital 
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acquisition board (Signatec PDA14, Corona, CA). The hydrophone was positioned at the 
focus of the transducer and translated laterally to measure a 4 mm extent of the beam profile 
at the focal depth (15 mm for RMV 710B). In acoustic angiography the resolution is 
primarily dictated by the high frequency receiving transducer, and we have recently 
characterized axial resolution for microbubble superharmonic imaging at across a wide 
range of frequencies (Lindsey et al. 2014). Relative to the study of Hu et al. (Hu et al. 2013), 
our own data indicate that axial resolution might be expected to decrease from ~250 µm at 
frequencies of 2/15 MHz to ~170 µm at 4/25 MHz, providing slightly improved resolution, 
though contrast-to-tissue ratio is expected to decrease with increasing receiving frequency. 
Therefore, line spacing in a 2-D image is determined by the resolution of the high frequency 
element. Manufacturer-provide information on scan geometry was used to compute line 
spacing at the focus (43 µm) in order to determine the overlap of the low frequency transmit 
pulse in adjacent lines.
In vitro microbubble targeting was achieved using biotinylated microbubbles and an avidin-
coated cellulose tube. First, the 200 µm (inner diameter) cellulose tube (Spectrum Labs, 
Rancho Dominguez, CA) was infused with 100% ethanol, which was then cleared by filling 
the tube with air. Next the tube was filled with a 5 mg/mL solution of avidin (Sigma-
Aldrich, St. Louis, MO) in phosphate-buffered saline (PBS) and allowed to sit at room 
temperature for 30 minutes before being flushed with PBS and positioned in a water bath at 
the focus of the dual-frequency transducer. An infusion of 5×104 biotin-coated microbubbles 
in 300 µL of PBS was pumped through the tube at a rate of 30 µL/min (Harvard Apparatus 
PHD2000, Holliston, MA), followed by a 10 min flush of pure PBS to remove any unbound 
microbubbles. 2-D images of the bound microbubbles were acquired for 100 frames at a 
frame rate of 1 Hz at peak negative pressures of 200, 350, and 500 kPa. Then, image clips 
were exported and analyzed in ImageJ (U. S. National Institutes of Health, Bethesda, MD). 
An image of the tube prior to contrast infusion was subtracted from each set of acquired 
images to eliminate any non-microbubble artifacts, then a region of interest was defined 
around the tube to compute image intensity. Experiments were repeated in triplicate and 
results were averaged together for each transmit pressure tested. A new tube was prepared 
with a new microbubble injection for each trial.
Microbubble preparation for in vivo studies
Microbubbles targeted to the αvβ3 integrin were created with an 18:1:1 molar ratio of 
DSPC, DSPE-PEG2000, and DSPE-PEG2000-maleimide cross-linked to the peptide Cyclo-
Arg-Gly-Asp-D-Tyr-Cys (cyclic RGD, Peptides International - Louisville, KY) in 
phosphate-buffered saline (PBS) (Fisher Scientific, Pittsburgh, PA). The cyclic RGD peptide 
targets vessels expressing αvβ3 integrin, which is characteristic of angiogenic tumors 
(Ellegala et al. 2003; Leong-Poi et al. 2003; Dayton et al. 2004; Streeter et al. 2010; 
Anderson et al. 2011; Streeter et al. 2011; Hu et al. 2013).
Previous investigations of the relationship between microbubble diameter and molecular 
imaging (Streeter et al. 2010) and contrast-to-tissue ratio in acoustic angiography imaging 
(Lindsey et al. 2014) both demonstrated improved performance for bubbles having diameters 
in the range of 3–4 µm rather than 1–2 µm. Additionally, larger bubbles are likely to produce 
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superharmonic signals over a greater number of pulses than smaller bubbles (Lindsey et al. 
2015). In order to examine the effect of microbubble diameter on superharmonic imaging in 
vivo, two populations of microbubbles were prepared: a polydisperse population as 
described in our in vitro studies with a mode diameter of approximately 1.4 µm, and larger 
diameter microbubbles enriched using differential centrifugal separation (Feshitan et al. 
2009; Streeter et al. 2010) with a mode diameter of approximately 3.8 µm.
Animal care and imaging
The Fisher 344 fibrosarcoma (FSA) model was prepared as previously described (Yuan et al. 
2006). In vivo imaging occurred when tumors reached approximately 1 cm in diameter. Rats 
were anesthetized with vaporized isoflurane and oxygen, and a 24 gauge catheter was 
inserted into the tail vein. Fur was removed from the imaging region by shaving and 
chemical depilation, and ultrasound gel was applied to the skin. Body temperature was 
maintained throughout using a heated imaging stage, and rats were secured to the imaging 
platform with surgical tape to minimize motion during the study. Acquisition times were less 
than 1 minute for the molecular volume and between 1 and 2 minutes for the microvascular 
volume. All animal experiments were performed in accordance with The University of North 
Carolina at Chapel Hill Institutional Animal Care and Use Committee.
Using the same VisualSonics 770 system and prototype transducer, tumor location was first 
identified in high frequency B-mode imaging. Next, a dual-frequency image was acquired 
prior to contrast agent administration for identification of any tissue artifacts. A bolus of 
5×107 cyclic RGD microbubbles was injected through the tail-vein catheter. After a 12 
minute wait, circulating microbubbles had cleared, and 3-D images of targeted microbubbles 
were acquired in dual-frequency mode with a step size of 250 µm between 2D images to 
avoid destroying bubbles in the adjacent imaging plane. The 12 minute wait for targeting is 
similar to that used in previous ultrasound molecular imaging studies (Kaufmann et al. 2007; 
Inaba and Lindner 2012; Wang et al. 2015b) and was determined based on prior scanning of 
two animals in which the degree of free bubbles in circulation was assessed every 4 minutes 
post-injection for 28 min. To test the expected improvement due to increased microbubble 
diameter, molecular imaging scans were acquired consecutively with size sorted (larger) and 
polydisperse (smaller) microbubbles in the same animal, with any remaining bound 
microbubbles destroyed between bolus injections by performing a scan at a peak negative 
pressure of 1400 kPa. The order in which the pressures were tested was randomized in order 
mitigate any potential effects of repeated boluses, which are expected to be negligible 
(Streeter and Dayton 2013). To examine microbubble destruction over repeated imaging, 
four 3-D scans were acquired at each set of parameters (microbubble diameter, pressure). 
Following the acquisition of molecular images, conventional dual-frequency acoustic 
angiography images were acquired using a constant infusion of 1.5×108 untargeted 
microbubbles/min, a peak negative pressure of 1.2 MPa, and a step size of 100 µm between 
2D images.
Image processing and analysis
Volumetric image data of targeted microbubbles were imported into ImageJ, and background 
noise was reduced by subtracting the background using the “rolling ball” algorithm with a 
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radius of 30 (Sternberg 1983). Tissue signal was reduced by subtracting a volume acquired 
before contrast agent injection. In MATLAB (The MathWorks Inc., Natick, MA), 
thresholding was applied to remove any remaining noise. The image intensities in 
volumetric tumor regions were calculated for each scan, and the average intensity of 
successive scans were normalized to the first scan in order to compare the relative loss of 
signal due to microbubble destruction. Acoustic angiography and molecular imaging 
volumes for the same animals were combined into a single volume in ImageJ by inserting 
blank frames into the molecular imaging volumes so that the slice spacing matched that of 
the acoustic angiography volumes, then merging the two volumes using different colors, 
with acoustic angiography data displayed in white and targeting information displayed in 
green.
For n=5 animals, individual vessels were segmented from acoustic angiography image 
volumes using centerline extraction via height ridge traversal with manually defined seed 
points (Aylward and Bullitt 2002). Coordinates of segmented vessels as well as coordinates 
and voxel intensities of the targeting sites from the molecular imaging data were read into 
MATLAB. Vessel coordinates were down-sampled to match the image spacing of the 
molecular imaging data. In order to analyze spatial relationships between resolvable vessels 
and targeted microbubble signal, distances between the targeting site and the five closest 
vessels were computed for each targeting site. Any registration artifacts due to differences in 
respiratory motion between sequential scans were assumed to be negligible. Previous studies 
indicate that the mean root-mean-square (RMS) error between two consecutive frames due 
to physiological motion is 7.2 ± 3.3 µm. Vessel diameters for these five closest vessels were 
also recorded for each targeting site.
Results
In vitro
Transmit pressure profiles were created at peak negative pressures of 200, 350, and 500 kPa 
at 4 MHz (Figure 1A) in order to visualize pressure levels incident on neighboring 
microbubbles from a single low frequency transmit event. With a mechanically-steered 
transducer, a single microbubble in the field is subject to increasing pressures from the low 
frequency element as the transducer arm moves towards the microbubble. Thus by the time 
both the peak transmit pressure and the focus of the high frequency receive element are 
aligned to the microbubble for acquisition of the imaging line, the microbubble has already 
experienced several pulses at increasing pressures. Figure 1B contains a diagram describing 
the motion of the transducer across ten imaging lines occupying 388 µm of the image in the 
lateral direction (only three transducer positions are shown instead of ten for clarity). A 
single microbubble positioned at the location of line 10 receives gradually increasing 
pressures with each transmit pulse as the transducer moves from line 1 to line 10. Figure 2 
depicts this overlapping spacing of the ten low frequency transmit pulses for the 350 kPa 
case. Vertical lines delineate the transmit line spacing of 43.1 µm and horizontal lines show 
the magnitude of negative pressure experienced by a bubble at location zero (in focus at line 
10) for preceding transmit events.
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Bound microbubbles in cellulose tubes were observed over 100 frames to assess frame-to-
frame decreases in signal intensity due to microbubble destruction by the transmit pulses 
(Figure 3). As expected, initial intensity of the targeted microbubble signal is directly related 
to the peak negative pressure of the transmit pulse. All three pressures (200, 350 and 500 
kPa, peak negative pressure) demonstrated some loss of signal from the initial transmit 
pulse, likely due to the preferential destruction of small microbubbles (Lindsey et al. 2015). 
However, observations at 200 and 350 kPa indicate relatively slow decline in microbubble 
signal, with a greater decrease in intensity observed for the 500 kPa test case. At the lowest 
pressure (200 kPa), the bound microbubble signal remained relatively stable across the 100 
transmit pulses, indicating minimal destruction. However, the intensities of the 
superharmonic echoes received by the high frequency element were low for the 200 kPa 
transmit pressure case. At the highest pressure (500 kPa), average intensity decreased 
quickly in the first few frames, and then decayed slowly over approximately frames 10–100. 
With the moderate pressure (350 kPa), the intensity decreased gradually over all 100 frames 
and exhibited greater microbubble signal than the observations at 200 and 500 kPa by frame 
3. Overall, in vitro results indicated that a balance between microbubble destruction and 
generation of broadband superharmonic signals might be achievable for bound microbubbles 
for in vivo molecular imaging.
In vivo
Imaging of microbubbles targeted to the αvβ3 integrin demonstrated little to no detectable 
signal in vivo at the low peak negative pressures examined in vitro. Therefore, the pressures 
tested were increased to non-derated values of 700, 900, and 1200 kPa. Several reasons 
account for the need for greatly increased pressures in vivo, including attenuation, small 
vessel confinement effects, and blood viscosity. For example, for an imaging depth of 15 
mm, an attenuation of 0.2 dB/cm/MHz in overlying tissues represents a loss of 1.2 dB at 4 
MHz. Superharmonic signals from the relatively few bubbles under the high frequency focus 
are also difficult to detect at the transducer, as the same attenuation of 0.2 dB/cm/MHz 
results in attenuations of 9 dB at 30 MHz. Additionally, Caskey et al. have reported that 
microbubble oscillation is constrained when bubbles are confined to smaller vessels in vivo, 
measuring a relative expansion of a factor of 4–11.5 in 200 µm-inner diameter tubes in vitro 
as compared to a mean relative expansion of 1.5 in ex vivo vessels less than 30 µm in 
diameter (Caskey et al. 2007). This may indicate higher pressures are required to produce 
superharmonic signals in small vessels. Other authors have investigated the effect of blood 
viscosity on microbubble oscillation, finding that microbubble resonance is severely altered 
in the presence of viscous damping (Khismatullin 2004; Sassaroli and Hynynen 2004).
With these higher pressures, it was possible to create in vivo images of bound microbubbles 
which could be overlaid on acoustic angiography image volumes as a reference for vascular 
structure. Note that these molecular imaging volumes could also be overlaid on B-mode 
images, as is customary in ultrasound molecular imaging. Figure 4 shows fused maximum 
intensity projections of molecular and acoustic angiography images in the lateral view (4A) 
and dorsal-ventral view (4B) of a tumor approximately 1 cm in diameter, using a 
polydisperse population of microbubbles (1–2 µm diameter) and a peak negative pressure of 
1200 kPa. The relative decrease in image intensity over four successive scans in the same 
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five animals for both sorted or polydisperse microbubble populations is shown in Figure 5. 
During the first scan, the larger sorted microbubbles were clearly brighter than the first scan 
of the polydisperse population, but the difference between the signal from each population 
decreased through scan 4, when neither microbubble population yielded significant 
detectable signal at a transmit peak negative pressure of 1200 kPa.
In comparing image intensity for the size-sorted microbubbles at pressures of 700, 900, and 
1200 kPa in the same animal, the higher pressures were found to produce the greatest image 
intensity from bound microbubbles. Figure 6 shows example image overlays of acoustic 
angiography and molecular imaging at the three pressures tested in a single representative 
animal. At higher pressures, both the brightness of individual targeting sites and the number 
of detectable targeting sites were visibly greater. The relative image intensities of the 3 
different peak negative insonation pressures were computed across four scans until very little 
signal was detectable at any pressure, and this data is shown in Figure 7 for all 5 animals. 
The plot in Figure 7 shows that the mean image intensity in targeted microbubble images at 
700 kPa is fairly constant over four scans, although the mean image intensity value is low. 
At higher pressures, the mean initial intensity of scan 1 improved, but there was a greater 
decline in image intensity with each successive scan. The greatest targeting signal intensity 
resulted from the first scan at 1200 kPa, the highest peak negative pressure tested.
Segmentation of vessels visible in acoustic angiography images acquired with a constant 
infusion of microbubbles allowed comparison of the spatial distribution of targeted 
microbubbles and vascular structure. Following segmentation, distances from each targeting 
site to the 5 nearest vessels and the diameters of those vessels were computed in MATLAB 
(see Figure 8). The majority of targeting sites were within 50 µm of the centerline of a 
resolvable vessel, and very few targeting sites were located farther than 150 µm from a 
segmented vessel (Figure 8A). Additionally, we observed that the majority of targeting 
occurred in small vessels. Figure 8B shows that αvβ3 targeting increased as vessels 
decreased in diameter, with a decline in the percentage of targeting sites located in or near 
vessels 100–200 µm in diameter, which is approximately the resolution limit of the acoustic 
angiography images. The relationship between vessel diameter and levels of targeted 
microbubble detection may be related to purely physical implications of smaller diameter 
vessels, or to patterns of αvβ3 integrin expression.
Discussion
Bubble destruction and superharmonic molecular imaging
In this article we have demonstrated the feasibility of forming high resolution images of 
microbubbles targeted to the αvβ3 integrin using an imaging technique which forms images 
of only the superharmonic echoes of microbubbles. While this technique is known to be 
partially destructive, bound microbubbles persisted sufficiently long in vivo to allow for the 
formation of high resolution superharmonic molecular images (Figure 4). Although image 
intensity decreased rapidly with each subsequent scan (Figure 5, Figure 7), superharmonic 
echoes were detectable on the initial scan despite the fact that microbubbles had already 
been subjected to multiple pulses due to the large focal size of the low frequency transducer 
element (Figure 1–2). This partial persistence of superharmonic signals over a few pulses is 
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consistent with the in vitro studies reported here (Figure 3) and previously (Lindsey et al. 
2015). We have also observed that superharmonic molecular imaging may be enhanced by 
using a microbubble population with a slightly larger diameter, consistent with previous 
observations that larger microbubbles improve sensitivity in conventional molecular imaging 
(Talu et al. 2007; Streeter et al. 2010) and in superharmonic imaging of free bubbles 
(Lindsey et al. 2014), and that larger free microbubbles are more prone to deflation over 
several pulses relative to smaller microbubbles (Lindsey et al. 2015). While microbubble 
persistence is clearly a challenge for this technique, acquiring useful superharmonic 
molecular images is possible on at least the first acquisition and appears to be aided by the 
use of microbubbles having slightly larger diameters. In addition, the use of higher 
microbubble concentrations might produce increased targeting more similar to conventional 
ultrasound molecular imaging approaches, but the current concentration allows spatial 
comparison between molecular and microvascular imaging volumes.
Potential improvements
While superharmonic molecular images with the highest image intensity were acquired with 
the highest pressure tested (1200 kPa), opportunities may remain for further optimization of 
transmit frequencies or pressures in order to either increase sensitivity of the initial scan or 
prolong the usefulness of the images over a greater number of scans. The effects of the in 
vivo environment on microbubble oscillation have not been precisely quantified, so the peak 
negative pressure required to induce microbubble deflation or destruction in vivo are unclear. 
Previous studies have reported that microbubbles persist longer as vessel size decreases 
(Caskey et al. 2007), however greater pressures may be required to produce superharmonic 
echoes from these bubbles. This suggests that in a field of view filled with vessels of varying 
diameter, microbubble oscillation and thus received signal may depend on vessel diameter. 
Thus sensitivity to smaller vessels may not be limited merely by the presence of fewer 
microbubbles or slower reperfusion rates in these vessels.
Due to the mechanical steering of the prototype transducer, each microbubble is subjected to 
many lower pressure pulses before the receiving focus is aligned over the microbubble. 
Additionally, bound microbubbles are subject to secondary Bjerknes forces which may cause 
detachment of bound microbubbles at low MI (Garbin et al. 2011; Gessner et al. 2012b; 
Loughran et al. 2012). These forces may induce microbubble unbinding in this method due 
to lower pressure pulses acting on a microbubble before the dual focus is aligned with the 
microbubble, potentially reducing sensitivity if detached microbubbles flow out of plane 
before being detected. Both of these effects (destruction and detachment of microbubbles 
outside of the receiving focus) could be mitigated by using a transducer having transmit and 
receive foci which were more similar in size, as the lateral resolution of the high frequency 
element is 140 µm (710B) while that of the low frequency element is ~1 mm. Alternatively, 
a dual-frequency array transducer would allow all echoes to be received by the high 
frequency array even with a large transmit focus (Bouakaz et al. 2002; Stephens et al. 2006; 
Martin et al. 2014).
Use of an array would also help mitigate any effects of motion artifacts in the spatial 
comparison between vascular and molecular imaging data by allowing increased acquisition 
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rates and providing a more uniform acoustic field. However, because vessel centerlines are 
extracted using the described segmentation technique, single frame shift errors due to animal 
respiration are removed from microvasculature imaging data. This means that only the 
molecular imaging data is subject to the effects of motion artifacts. However, the fact that 
results indicate meaningful spatial relationships between vessel diameter and distance to 
targeting sites (Fig. 8) suggests that any motion effects in the molecular imaging datasets are 
sufficiently small as to permit this type of analysis with the current system.
The use of chirped excitation may be an alternative means for improving sensitivity to bound 
microbubbles, which has previously been demonstrated in contrast imaging (Borsboom et al. 
2005; Sun et al. 2006; Leavens et al. 2007; Sun et al. 2007). While this may enable 
molecular imaging of microbubbles of varying diameters at lower peak pressures, these 
pulses have not been assessed in superharmonic contrast imaging, in which the highest 
amplitude echoes are produced by microbubble destruction (Lindsey et al. 2015). This 
suggests that short pulses may be more effective for superharmonic imaging because they 
induce microbubble destruction over a smaller volume than longer pulses. Use of chirped 
pulses also depends on the ability of the transducer to transmit a pulse without distortion 
(Lindsey et al. 2015).
Value of combined molecular and vascular imaging
The combination of molecular imaging and acoustic angiography provides opportunities for 
investigating the spatial distribution of functional biomarkers and vascular structures in 
concert. Given that ultrasound molecular imaging utilizes vascular targets, combining 
ultrasound molecular imaging with angiography images mapping vascular structure provides 
the unique opportunity to analyze relationships between vascular features and molecular 
information. In this work, we have observed that cyclic RGD microbubbles targeted to the 
αvβ3 integrin were detected preferentially in smaller vessels, and that all targeting sites were 
located within 200 µm of a resolvable vessel, with the majority of targeting occurring within 
50 µm of a segmented vessel. Molecular targeting may be increased in small vessels due to 
slower blood flow velocities or the increasing similarity between microbubble and vessel 
diameters, which may improve the probability of binding (Takalkar et al. 2004; Kaufmann et 
al. 2007). Alternatively, binding in larger vessels may prove transient or more challenging 
due to detachment caused by greater shear flow, with binding efficiency in shear flow also 
dependent upon ligand concentration on the microbubble surface (Klibanov et al. 2006; Patil 
et al. 2011). Smaller vessels may also retain bubbles which detach due to either shear flow 
or ultrasound for a longer time period.
However, straightforward relationships between vessel diameter and flow rate do not hold in 
tumors due to the formation of abnormal vascular networks created by tumor angiogenesis 
(Jain 1988). The spatial distribution of integrin expression may also vary with vessel 
diameter, as previous investigations have reported that molecular targets of angiogenesis, 
such as vascular endothelial growth factor (VEGF) or the αvβ3 integrin used in this work 
may be more prevalent in small vessels undergoing active remodeling (Brooks et al. 1994). 
While the exact relationship between vessel anatomy and molecular targeting is unclear, the 
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presented approach has demonstrated an initial ability to assess the sizes of vessels in which 
targeting occurs in pre-clinical studies.
Clinical translation of the described technique would be aided by developments in both 
scanning system and contrast agent technology. While there are no fundamental limitations 
which prevent the mechanically-steered dual-frequency transducer from being used 
clinically for superharmonic imaging, a dual-frequency array transducer would allow for 
greater control over the pressure field, ensuring a more uniform point spread function over a 
larger field of view while maintaining the contrast-to-tissue ratio and spatial resolution of the 
presented images. Clinical use of ultrasound molecular imaging is presently limited by the 
lack of FDA-approved targeted microbubble contrast agents, however, clinically translatable 
contrast agents have recently been developed such as BR55 from Bracco (Pochon et al. 
2010; Pysz et al. 2010). Once targeted contrast agents are developed and approved, the 
described technique for superharmonic molecular imaging could enable ultrasound 
molecular imaging with higher resolution in all the applications currently under investigation 
including angiogenesis (Pochon et al. 2010), inflammation (Wang et al. 2013), and cancers 
of the breast (Bachawal et al. 2013), colon (Wang et al. 2015a), and prostate (Tardy et al. 
2010). Combining a higher resolution molecular image with a registered angiography-like 
image provides additional information on microvascular morphology relative to the 
previously demonstrated ultrasound molecular images for these applications, in which 
molecular images are displayed against a background B-mode image.
In addition, the ability to visualize both microvascular anatomy and molecular targeting may 
also be of clinical use by providing currently unavailable information on the growth and 
extent of an individual tumor. For example, imaging αvβ3 expression has previously been 
demonstrated using PET and SPECT in tumors of the breast and brain (Bach-Gansmo et al. 
2006; Beer et al. 2008; Schnell et al. 2009), and also using near-infrared fluorescence 
imaging in colorectal tumors (Verbeek et al. 2014). The PET imaging studies utilized an 18F-
cyclic RGD tracer and then validated imaging results using post-resection 
immunohistochemistry, finding that while αvβ3 imaging is effective at locating tumors, its 
expression is “highly variable” (Beer et al. 2008; Schnell et al. 2009). While this 
heterogeneous expression of αvβ3 and the poor spatial resolution of PET make it difficult to 
use PET alone as either a screening test or a surgical planning tool, the high resolution 3D 
vascular and targeting information provided by acoustic angiography could make for an 
excellent tool for surgical planning after initial tumor localization. In this case, the 
expression of αvβ3 on both endothelial and tumor cells, as identified in prior PET studies 
(Beer et al. 2008), could prove helpful for ensuring resection with clean margins.
Conclusions
We have presented an ultrasound-based approach for both imaging vasculature and 
molecular markers with high spatial resolution. This technique uses a prototype dual-
frequency transducer to acquire only superharmonic signals produced by microbubble 
contrast agents. Although the imaging process was observed to produce decreasing image 
brightness over time in vitro due to destruction of bound microbubbles, combinations of 
transmit pressure and frequency can be chosen which prolong microbubble persistence. 
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Under such parameters, diagnostically useful superharmonic molecular images may be 
acquired. In this study, we have demonstrated high resolution superharmonic molecular 
imaging in a rodent tumor model (fibrosarcoma) using microbubbles targeted to the αvβ3 
integrin. A second scan of free microbubbles was acquired immediately following the 
molecular scan, and the two imaging volumes were fused to provide 3D visualization of both 
microvascular anatomy and biodistribution of the αvβ3 integrin. Mapping both biomarkers 
and microvascular anatomy with high resolution provides a new method for visualizing 
molecular markers with ultrasound while using ultrasound-based angiography-like mapping 
to provide anatomical information. The combined information provided by these scans may 
present new opportunities for analyzing relationships between microvascular anatomy and 
vascular targets for microbubbles such as integrins, selectins, and other extracellular binding 
domains.
Acknowledgments
This research was supported by National Institutes of Health 1R01CA170665, as well as training grant 
T32HL069768. We thank Mike Lee, Emmanuel Cherin, and Chris Chaggares for their contributions to the design 
and fabrication of prototype transducers. We would also like to acknowledge Elizabeth Bullitt and Stephen R. 
Aylward for guidance and algorithms for vessel segmentation. Paul Dayton declares that he has equity in SonoVol 
Inc., which has licensed some of the technology described in this manuscript.
References
Anderson CR, Hu X, Zhang H, Tlaxca J, Decleves AE, Houghtaling R, Sharma K, Lawrence M, 
Ferrara KW, Rychak JJ. Ultrasound molecular imaging of tumor angiogenesis with an integrin 
targeted microbubble contrast agent. Investigative radiology. 2011; 46:215–24. [PubMed: 
21343825] 
Aylward SR, Bullitt E. Initialization, noise, singularities, and scale in height ridge traversal for tubular 
object centerline extraction. IEEE transactions on medical imaging. 2002; 21:61–75. [PubMed: 
11929106] 
Bach-Gansmo T, Danielsson R, Saracco A, Wilczek B, Bogsrud TV, Fangberget A, Tangerud A, Tobin 
D. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-
NC100692. J Nucl Med. 2006; 47:1434–9. [PubMed: 16954550] 
Bachawal SV, Jensen KC, Lutz AM, Gambhir SS, Tranquart F, Tian L, Willmann JK. Earlier detection 
of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer research. 
2013; 73:1689–98. [PubMed: 23328585] 
Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nahrig J, Watzlowik P, Wester HJ, Harbeck N, Schwaiger 
M. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 
18F-Galacto-RGD PET. J Nucl Med. 2008; 49:255–9. [PubMed: 18199623] 
Borsboom JM, Chin CT, Bouakaz A, Versluis M, de Jong N. Harmonic chirp imaging method for 
ultrasound contrast agent. IEEE transactions on ultrasonics, ferroelectrics, and frequency control. 
2005; 52:241–9.
Bouakaz A, Frigstad S, Ten Cate FJ, de Jong N. Super harmonic imaging: A new imaging technique 
for improved contrast detection. Ultrasound in Medicine and Biology. 2002; 28:59–68. [PubMed: 
11879953] 
Bouakaz A, Krenning BJ, Vletter WB, ten Cate FJ, De Jong N. Contrast superharmonic imaging: a 
feasibility study. Ultrasound in medicine & biology. 2003; 29:547–53. [PubMed: 12749924] 
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin alpha 
v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. 
Cell. 1994; 79:1157–64. [PubMed: 7528107] 
Shelton et al. Page 14
Ultrasound Med Biol. Author manuscript; available in PMC 2017 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Caskey CF, Stieger SM, Qin S, Dayton PA, Ferrara KW. Direct observations of ultrasound 
microbubble contrast agent interaction with the microvessel wall. Journal of the Acoustical Society 
of America. 2007; 122:1191–200. [PubMed: 17672665] 
Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated 
PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung 
cancer. The Annals of thoracic surgery. 2004; 78:1017–23. discussion -23. [PubMed: 15337041] 
Dayton PA, Pearson D, Clark J, Simon S, Schumann PA, Zutshi R, Matsunaga TO, Ferrara KW. 
Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular 
imaging of alphavbeta3-expressing cells. Mol Imaging. 2004; 3:125–34. [PubMed: 15296677] 
Denbeigh JM, Nixon BA, Hudson JM, Puri MC, Foster FS. VEGFR2-targeted molecular imaging in 
the mouse embryo: an alternative to the tumor model. Ultrasound in medicine & biology. 2014; 
40:389–99. [PubMed: 24342913] 
Doinikov AA, Haac JF, Dayton PA. Resonance frequencies of lipid-shelled microbubbles in the regime 
of nonlinear oscillations. Ultrasonics. 2009; 49:263–8. [PubMed: 18977009] 
Dunleavey JM, Xiao L, Thompson J, Kim MM, Shields JM, Shelton SE, Irvin DM, Brings VE, Ollila 
DW, Brekken RA, Dayton PA, Melero-Martin JM, Dudley AC. Vascular channels formed by 
subpopulations of PECAM1+ melanoma cells. Nature communications. 2014; 5:5200.
Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR. 
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. 
Circulation. 2003; 108:336–41. [PubMed: 12835208] 
Faez T, Goertz D, De Jong N. Characterization of Definity ultrasound contrast agent at frequency 
range of 5–15 MHz. Ultrasound in medicine & biology. 2011; 37:338–42. [PubMed: 21257093] 
Feshitan JA, Chen CC, Kwan JJ, Borden MA. Microbubble size isolation by differential centrifugation. 
Journal of colloid and interface science. 2009; 329:316–24. [PubMed: 18950786] 
Foster FS, Hossack J, Adamson SL. Micro-ultrasound for preclinical imaging. Interface Focus. 2011; 
1:576–601. [PubMed: 22866232] 
Foster FS, Mehi J, Lukacs M, Hirson D, White C, Chaggares C, Needles A. A new 15–50 MHz array-
based micro-ultrasound scanner for preclinical imaging. Ultrasound in medicine & biology. 2009; 
35:1700–8. [PubMed: 19647922] 
Garami Z, Hascsi Z, Varga J, Dinya T, Tanyi M, Garai I, Damjanovich L, Galuska L. The value of 18-
FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an 
emphasis on changes in disease stage designation and treatment plan. European journal of surgical 
oncology : the journal of the European Society of Surgical Oncology and the British Association 
of Surgical Oncology. 2012; 38:31–7.
Garbin V, Overvelde M, Dollet B, de Jong N, Lohse D, Versluis M. Unbinding of targeted ultrasound 
contrast agent microbubbles by secondary acoustic forces. Phys Med Biol. 2011; 56:6161–77. 
[PubMed: 21878709] 
Gessner R, Lukacs M, Lee M, Cherin E, Foster FS, Dayton PA. High-resolution, high-contrast 
ultrasound imaging using a prototype dual-frequency transducer: in vitro and in vivo studies. IEEE 
transactions on ultrasonics, ferroelectrics, and frequency control. 2010; 57:1772–81.
Gessner RC, Aylward SR, Dayton PA. Mapping microvasculature with acoustic angiography yields 
quantifiable differences between healthy and tumor-bearing tissue volumes in a rodent model. 
Radiology. 2012a; 264:733–40. [PubMed: 22771882] 
Gessner RC, Frederick CB, Foster FS, Dayton PA. Acoustic angiography: a new imaging modality for 
assessing microvasculature architecture. International journal of biomedical imaging. 2013; 
2013:936593. [PubMed: 23997762] 
Gessner RC, Streeter JE, Kothadia R, Feingold S, Dayton PA. An in vivo validation of the application 
of acoustic radiation force to enhance the diagnostic utility of molecular imaging using 3-d 
ultrasound. Ultrasound in medicine & biology. 2012b; 38:651–60. [PubMed: 22341052] 
Helfield BL, Goertz DE. Nonlinear resonance behavior and linear shell estimates for Definity and 
MicroMarker assessed with acoustic microbubble spectroscopy. The Journal of the Acoustical 
Society of America. 2013; 133:1158–68. [PubMed: 23363132] 
Hu X, Caskey CF, Mahakian LM, Kruse DE, Beegle JR, Decleves AE, Rychak JJ, Sutcliffe PL, 
Sharma K, Ferrara KW. In vivo validation and 3D visualization of broadband ultrasound molecular 
Shelton et al. Page 15
Ultrasound Med Biol. Author manuscript; available in PMC 2017 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
imaging. American journal of nuclear medicine and molecular imaging. 2013; 3:336–49. 
[PubMed: 23901359] 
Hu XW, Zheng HR, Kruse DE, Sutcliffe P, Stephens DN, Ferrara KW. A Sensitive TLRH Targeted 
Imaging Technique for Ultrasonic Molecular Imaging. Ieee T Ultrason Ferr. 2010; 57:305–16.
Hyvelin JM, Tardy I, Bettinger T, von Wronski M, Costa M, Emmel P, Colevret D, Bussat P, Lassus A, 
Botteron C, Nunn A, Frinking P, Tranquart F. Ultrasound molecular imaging of transient acute 
myocardial ischemia with a clinically translatable P- and E-selectin targeted contrast agent: 
correlation with the expression of selectins. Investigative radiology. 2014; 49:224–35. [PubMed: 
24442162] 
Inaba Y, Lindner JR. Molecular imaging of disease with targeted contrast ultrasound imaging. 
Translational research : the journal of laboratory and clinical medicine. 2012; 159:140–8. 
[PubMed: 22340763] 
Jain RK. Determinants of tumor blood flow: a review. Cancer research. 1988; 48:2641–58. [PubMed: 
3282647] 
Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Current opinion in 
biotechnology. 2007; 18:11–6. [PubMed: 17241779] 
Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ, Lindner JR. Molecular imaging 
of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion 
molecule-1. Circulation. 2007; 116:276–84. [PubMed: 17592078] 
Khismatullin DB. Resonance frequency of microbubbles: effect of viscosity. The Journal of the 
Acoustical Society of America. 2004; 116:1463–73. [PubMed: 15478411] 
Klibanov AL, Rychak JJ, Yang WC, Alikhani S, Li B, Acton S, Lindner JR, Ley K, Kaul S. Targeted 
ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast 
media & molecular imaging. 2006; 1:259–66. [PubMed: 17191766] 
Kruse DE, Ferrara KW. A new imaging strategy using wideband transient response of ultrasound 
contrast agents. Ieee T Ultrason Ferr. 2005; 52:1320–9.
Leavens C, Williams R, Foster FS, Burns PN, Sherar MD. Golay pulse encoding for microbubble 
contrast imaging in ultrasound. IEEE transactions on ultrasonics, ferroelectrics, and frequency 
control. 2007; 54:2082–90.
Leong-Poi H, Christiansen J, Heppner P, Lewis CW, Klibanov AL, Kaul S, Lindner JR. Assessment of 
endogenous and therapeutic arteriogenesis by contrast ultrasound molecular Imaging of integrin 
expression. Circulation. 2005; 111:3248–54. [PubMed: 15956135] 
Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. Noninvasive assessment of 
angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation. 2003; 
107:455–60. [PubMed: 12551871] 
Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node 
identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007; 48:201–
6. [PubMed: 17268015] 
Lindsey BD, Rojas JD, Martin KH, Shelton SE, Dayton PA. Acoustic characterization of contrast-to-
tissue ratio and axial resolution for dual-frequency contrast-specific acoustic angiography imaging. 
IEEE transactions on ultrasonics, ferroelectrics, and frequency control. 2014; 61:1668–87.
Lindsey BD, Shelton SE, Dayton PA. Optimization of contrast-to-tissue ratio through pulse windowing 
in dual-frequency "acoustic angiography" imaging. Ultrasound in medicine & biology. 2015; 
41:1884–95. [PubMed: 25819467] 
Liu H, Chen Y, Yan F, Han X, Wu J, Liu X, Zheng H. Ultrasound molecular imaging of vascular 
endothelial growth factor receptor 2 expression for endometrial receptivity evaluation. 
Theranostics. 2015; 5:206–17. [PubMed: 25553109] 
Liu H, Jiang YX, Liu JB, Zhu QL, Sun Q. Evaluation of breast lesions with contrast-enhanced 
ultrasound using the microvascular imaging technique: Initial observations. Breast. 2008; 17:532–
9. [PubMed: 18534851] 
Loughran J, Sennoga C, R JE, Tang MX. Effect of ultrasound on adherent microbubble contrast agents. 
Phys Med Biol. 2012; 57:6999–7014. [PubMed: 23044731] 
Shelton et al. Page 16
Ultrasound Med Biol. Author manuscript; available in PMC 2017 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Martin KH, Lindsey BD, Ma J, Lee M, Li S, Foster FS, Jiang X, Dayton PA. Dual-Frequency 
Piezoelectric Transducers for Contrast Enhanced Ultrasound Imaging. Sensors. 2014; 14:20825–
42. [PubMed: 25375755] 
Patil AV, Rychak JJ, Klibanov AL, Hossack JA. Real-time technique for improving molecular imaging 
and guiding drug delivery in large blood vessels: in vitro and ex vivo results. Mol Imaging. 2011; 
10:238–47. [PubMed: 21521555] 
Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M. 
BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of 
angiogenesis. Investigative radiology. 2010; 45:89–95. [PubMed: 20027118] 
Pysz MA, Foygel K, Panje CM, Needles A, Tian L, Willmann JK. Assessment and monitoring tumor 
vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. 
Investigative radiology. 2011; 46:187–95. [PubMed: 21150790] 
Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK. Antiangiogenic cancer 
therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). 
Radiology. 2010; 256:519–27. [PubMed: 20515975] 
Roach PJ, Schembri GP, Shon IAH, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT 
scanner for anatomical localization: Impact on diagnostic accuracy and reporter confidence in 
clinical practice. Nucl Med Commun. 2006; 27:977–87. [PubMed: 17088684] 
Rychak JJ, Graba J, Cheung AM, Mystry BS, Lindner JR, Kerbel RS, Foster FS. Microultrasound 
molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor 
angiogenesis. Mol Imaging. 2007; 6:289–96. [PubMed: 18092513] 
Sassaroli E, Hynynen K. Forced linear oscillations of microbubbles in blood capillaries. The Journal of 
the Acoustical Society of America. 2004; 115:3235–43. [PubMed: 15237848] 
Satinover SJ, Dove JD, Borden MA. Single-particle optical sizing of microbubbles. Ultrasound in 
medicine & biology. 2014; 40:138–47. [PubMed: 24139917] 
Schnell O, Krebs B, Carlsen J, Miederer I, Goetz C, Goldbrunner RH, Wester HJ, Haubner R, Popperl 
G, Holtmannspotter M, Kretzschmar HA, Kessler H, Tonn JC, Schwaiger M, Beer AJ. Imaging of 
integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD 
positron emission tomography. Neuro-oncology. 2009; 11:861–70. [PubMed: 19401596] 
Shelton SE, Lee YZ, Foster FS, Lee M, Cherin E, Aylward SR, Dayton PA. Quantification of 
microvascular tortuosity during tumor evolution utilizing acoustic angiography. Ultrasound in 
medicine & biology. 2015 Accepted for publication: 
Sirsi S, Feshitan J, Kwan J, Homma S, Borden M. Effect of microbubble size on fundamental mode 
high frequency ultrasound imaging in mice. Ultrasound in medicine & biology. 2010; 36:935–48. 
[PubMed: 20447755] 
Soyka JD, Muster MA, Schmid DT, Seifert B, Schick U, Miralbell R, Jorcano S, Zaugg K, Seifert HH, 
Veit-Haibach P, Strobel K, Schaefer NG, Husarik DB, Hany TF. Clinical impact of 18F-choline 
PET/CT in patients with recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2012; 39:936–
43. [PubMed: 22415598] 
Sternberg S. Biomedical Image Processing. Computer. 1983; 16:22–34.
Streeter JE, Dayton PA. An in vivo evaluation of the effect of repeated administration and clearance of 
targeted contrast agents on molecular imaging signal enhancement. Theranostics. 2013; 3:93–8. 
[PubMed: 23424189] 
Streeter JE, Gessner R, Miles I, Dayton PA. Improving sensitivity in ultrasound molecular imaging by 
tailoring contrast agent size distribution: in vivo studies. Mol Imaging. 2010; 9:87–95. [PubMed: 
20236606] 
Streeter JE, Gessner RC, Tsuruta J, Feingold S, Dayton PA. Assessment of molecular imaging of 
angiogenesis with three-dimensional ultrasonography. Mol Imaging. 2011; 10:460–8. [PubMed: 
22201537] 
Sun Y, Kruse DE, Ferrara KW. Contrast imaging with chirped excitation. IEEE transactions on 
ultrasonics, ferroelectrics, and frequency control. 2007; 54:520–9.
Sun Y, Zhao S, Dayton PA, Ferrara KW. Observation of contrast agent response to chirp insonation 
with a simultaneous optical-acoustical system. IEEE transactions on ultrasonics, ferroelectrics, and 
frequency control. 2006; 53:1130–7.
Shelton et al. Page 17
Ultrasound Med Biol. Author manuscript; available in PMC 2017 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K. Binding and detachment dynamics of 
microbubbles targeted to P-selectin under controlled shear flow. Journal of controlled release : 
official journal of the Controlled Release Society. 2004; 96:473–82. [PubMed: 15120903] 
Talu E, Hettiarachchi K, Zhao S, Powell RL, Lee AP, Longo ML, Dayton PA. Tailoring the size 
distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular 
imaging. Mol Imaging. 2007; 6:384–92. [PubMed: 18053409] 
Tardy I, Pochon S, Theraulaz M, Emmel P, Passantino L, Tranquart F, Schneider M. Ultrasound 
Molecular Imaging of VEGFR2 in a Rat Prostate Tumor Model Using BR55. Investigative 
radiology. 2010; 45:573–8. [PubMed: 20808233] 
Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, Sandler MP, Delbeke D. 
Impact of I-131-SPECT/CT images obtained with an integrated system in the follow-up of patients 
with thyroid carcinoma. Eur J Nucl Med Mol I. 2004; 31:1435–42.
Verbeek FPR, van der Vorst JR, Tummers QRJG, Boonstra MC, de Rooij KE, Lowik CWGM, 
Valentijn ARPM, van de Velde CJH, Choi HS, Frangioni JV, Vahrmeijer AL. Near-Infrared 
Fluorescence Imaging of Both Colorectal Cancer and Ureters Using a Low-Dose Integrin Targeted 
Probe. Ann Surg Oncol. 2014; 21:S528–S37. [PubMed: 24515567] 
Voigt JU. Ultrasound molecular imaging. Methods. 2009; 48:92–7. [PubMed: 19324089] 
Wang H, Kaneko OF, Tian L, Hristov D, Willmann JK. Three-Dimensional Ultrasound Molecular 
Imaging of Angiogenesis in Colon Cancer Using a Clinical Matrix Array Ultrasound Transducer. 
Investigative radiology. 2015a
Wang H, Machtaler S, Bettinger T, Lutz AM, Luong R, Bussat P, Gambhir SS, Tranquart F, Tian L, 
Willmann JK. Molecular imaging of inflammation in inflammatory bowel disease with a clinically 
translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse 
model. Radiology. 2013; 267:818–29. [PubMed: 23371306] 
Wang SY, Hossack JA, Klibanov AL, Mauldin FW. Binding dynamics of targeted microbubbles in 
response to modulated acoustic radiation force. Phys Med Biol. 2014; 59:465–84. [PubMed: 
24374866] 
Wang SY, Mauldin FW, Klibanov AL, Hossack JA. Ultrasound-Based Measurement of Molecular 
Marker Concentration in Large Blood Vessels: A Feasibility Study. Ultrasound in Medicine and 
Biology. 2015b; 41:222–34. [PubMed: 25308943] 
Willmann JK, Kimura RH, Deshpande N, Lutz AM, Cochran JR, Gambhir SS. Targeted Contrast-
Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to 
Integrin-Binding Knottin Peptides. J Nucl Med. 2010; 51:433–40. [PubMed: 20150258] 
Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen 
X, Gambhir SS. US imaging of tumor angiogenesis with microbubbles targeted to vascular 
endothelial growth factor receptor type 2 in mice. Radiology. 2008; 246:508–18. [PubMed: 
18180339] 
Yan F, Li X, Jin Q, Chen J, Shandas R, Wu J, Li L, Ling T, Yang W, Chen Y, Liu X, Zheng H. 
Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro 
and in vivo studies. Ultrasound in medicine & biology. 2012; 38:670–80. [PubMed: 22341598] 
Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW. Intertumoral differences in 
hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). 
J Nucl Med. 2006; 47:989–98. [PubMed: 16741309] 
Shelton et al. Page 18
Ultrasound Med Biol. Author manuscript; available in PMC 2017 October 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
(A) Hydrophone-measured pressure maps as a transmit beam having a peak negative 
pressure of 200 kPa (solid line), 350 kPa (dotted line), or 500 kPa (dashed line) is swept 
from left to right. (B) Motion of transducer mechanical arm for the scenario in Fig. 1A. 
Illustration of transmitted pressure experienced by a single microbubble as the mechanically 
steered transducer arm moves from some distance away from the bubble (gray) to on-axis 
steering (black). Given a line separation of 43.1 µm, 10 adjacent lines occupy a distance of 
387.9 µm, over which a single bubble is exposed to multiple pulses of gradually increasing 
pressure until the on-axis bubble experiences the nominal peak negative pressure.
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Figure 2. 
Peak negative pressures (horizontal lines) in kPa experienced by a bubble at position 0, due 
to 10 adjacent scan lines with a line spacing of 43.1 µm (illustrated by the vertical lines).
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Figure 3. 
Image intensity vs. frame number for targeted biotin microbubbles adhered to an avidin-
coated tube. Each line indicates the mean result of 3 experiments.
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Figure 4. 
(A) Fused scans of vascular anatomy acquired using untargeted (grayscale) and cyclic RGD 
microbubbles (green) in sequential scans of a subcutaneous fibrosarcoma in the same 
animal. Images are shown here in a lateral view. (B) The same data in (A) is shown in a 
dorsal-ventral view. Both scale bars represent 2 mm.
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Figure 5. 
Image intensity over 4 consecutive scans with cyclic RGD bubbles in n=5 animals at non-
derated peak negative transmit pressures of 1200 kPa for both sorted and polydisperse cyclic 
RGD microbubble populations. Each scan was normalized to its initial intensity.
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Figure 6. 
The effect of varying peak transmit pressure on received molecular imaging signal (green) is 
illustrated in a single animal in both lateral (left) and dorsal-ventral views (right). The same 
acoustic angiography data (grayscale) was used to provide vascular anatomy for all cases.
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Figure 7. 
Image intensity over 4 consecutive scans with cyclic RGD bubbles in n=5 animals with 
varying peak negative transmit pressures of 700, 900, and 1200 kPa for size-sorted 
microbubble populations. Each scan was normalized to its initial intensity.
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Figure 8. 
Histograms of (A) the distance to the 5 closest resolvable vessels and (B) the mean diameter 
of these vessels in n=5 animals indicate that most targeting occurred close to a vessel 
approximately 100–300 µm in diameter.
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